FDA Approves First Biosimilar Insulin Product
THURSDAY, July 29, 2021 -- The first interchangeable biosimilar insulin product has been approved by the U.S. Food and Drug Administration, providing patients with a cost-effective option for treating diabetes, the agency announced... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Correction: FDA-Generic Insulin story
In a story published July 28, 2021, about pharmacists being allowed to automatically substitute a cheaper, near-copy for Lantus brand insulin, The Associated Press erroneously reported that Lantus is a fast-acting insulin (Source: ABC News: Health)
Source: ABC News: Health - July 29, 2021 Category: Consumer Health News Tags: Health Source Type: news

FDA OKs Automatic Use of a Cheaper Generic   Insulin
THURSDAY, July 29, 2021 -- U.S. pharmacists will now be able to automatically substitute a cheaper biosimilar for a more expensive brand-name insulin, the U.S Food and Drug Administration announced Wednesday. The agency's approval of an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2021 Category: General Medicine Source Type: news

FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is both biosimilar to, and interchangeable with (can be substituted for), its reference product Lantus (insulin glargine), a long-acting insulin analog. (Source: World Pharma News)
Source: World Pharma News - July 29, 2021 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA OKs Automatic Use of a Cheaper Generic Insulin
Title: FDA OKs Automatic Use of a Cheaper Generic InsulinCategory: Health NewsCreated: 7/29/2021 12:00:00 AMLast Editorial Review: 7/29/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - July 29, 2021 Category: Endocrinology Source Type: news

FDA Approves First Interchangeable Biosimilar Insulin FDA Approves First Interchangeable Biosimilar Insulin
Semglee is now both biosimilar to glargine and also interchangeable with Lantus, so it can be substituted at the pharmacy.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 29, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

FDA allows automatic 'generic' swap for brand-name insulin
U.S. regulators have taken action that will make it easier to get a cheaper and similar version of a brand-name insulin at the drugstore (Source: ABC News: Health)
Source: ABC News: Health - July 29, 2021 Category: Consumer Health News Tags: Health Source Type: news

Biocon Biologics interchangeable insulin Semglee gets US FDA approval
Biocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in the United States to treat diabetic patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Biocon's interchangeable insulin Semglee gets US FDA approval
Biocon partnered with global healthcare company Viatris Inc to develop Semglee, the first interchangeable biosimilar product approved in the United States to treat diabetic patients. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2021 Category: Pharmaceuticals Source Type: news

Biocon's Semglee gets USFDA approval; first interchangeable biosimilar product in US
“It is a milestone achievement for both Biocon Biologics and our partner Viatris. This will allow pharmacy level substitution and thereby provide convenient and affordable access to Semglee, a quality Biosimilar Insulin Glargine,” Biocon Biologics, Executive Chairperson, Kiran Mazumdar-Shaw said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Semglee (insulin glargine-yfgn) as the First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
SILVER SPRING, Md., July 28, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 28, 2021 Category: Drugs & Pharmacology Source Type: news

Postponed Weddings, Stockpiled Insulin and Covid: The Bizarre Life of Texas Democrats in Exile
What the Democratic state legislators from Texas are really doing in Washington—and how they got here. (Source: Reuters: Health)
Source: Reuters: Health - July 18, 2021 Category: Consumer Health News Source Type: news

HealthDay Now: Insulin Access
... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 15, 2021 Category: General Medicine Source Type: news

Fecal Transplantation and Fiber Improves Insulin in Obesity Fecal Transplantation and Fiber Improves Insulin in Obesity
"The potential for improving human health through the microbiome is immense. We are only scratching the surface at the moment," says the lead author of small new study.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 14, 2021 Category: Gastroenterology Tags: Diabetes & Endocrinology News Source Type: news

Beverly biotech shows promising Covid vaccine data, raises $19.5M
Just over a year after it expanded its mission well beyond insulin engineering, 10-year-old Akston Biosciences has revealed promising results from an early-stage study of its Covid-19 vaccine, which takes specific aim at thwarting variants. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 8, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

Best supplements: Powerful spice to help lower blood sugar and insulin resistance
SUPPLEMENTS could help to lower your chances of developing diabetes type 2 symptoms and signs in patients with high blood sugar. You could protect against diabetes by regularly adding these cheap capsules to your daily diet. (Source: Daily Express - Health)
Source: Daily Express - Health - July 7, 2021 Category: Consumer Health News Source Type: news

Insulin Degludec Better Than Glargine for Nighttime Hypos in T1D Insulin Degludec Better Than Glargine for Nighttime Hypos in T1D
In a head-to-head crossover study of 51 patients with type 1 diabetes and a history of nighttime hypoglycemia, insulin degludec halved the number of nighttime'lows'compared with glargine U100.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 6, 2021 Category: Neurology Tags: Diabetes & Endocrinology News Source Type: news

How to get rid of visceral fat: A fruit to burn belly fat due to flavanol & fibre content
HOW TO get rid of visceral fat can be far simpler than many may realise. In fact, it could be as simple as eating this one particular fruit daily due to its high flavanol and fibre content. The fruit is also synonymous with lower blood sugar and reduces insulin resistance which helps speed up the belly fat loss process. (Source: Daily Express - Health)
Source: Daily Express - Health - July 6, 2021 Category: Consumer Health News Source Type: news

Insulin-Pramlintide Combo Improves Type 1 Diabetes Control Insulin-Pramlintide Combo Improves Type 1 Diabetes Control
Novel investigational combined injection of insulin with amylin analog reduces post-meal glucose levels and body weight compared with premeal insulin alone.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 6, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Fecal transplant plus fibre improves insulin sensitivity in severely obese
(University of Alberta Faculty of Medicine& Dentistry) A transplant of healthy gut microbes followed by fibre supplements benefits patients with severe obesity and metabolic syndrome, according to University of Alberta clinical trial findings published today in Nature Medicine. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 6, 2021 Category: Biology Source Type: news

What's Best for Diabetes After Metformin? GRADE Outdated at Outset What's Best for Diabetes After Metformin? GRADE Outdated at Outset
The GRADE trial compared four different agents as add-ons to metformin for type 2 diabetes, and while liraglutide and insulin glargine fared best, the study is already outdated, said one commentator.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

CGM in Type 2 Diabetes: What I Learned From the MOBILE Study CGM in Type 2 Diabetes: What I Learned From the MOBILE Study
Anne Peters discusses the benefit of CGM in patients with type 2 diabetes on basal insulin, adding that there is much to be done in educating both patients and healthcare professionals about CGM.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

Walmart to Sell Cheaper Insulin; Advocates Say It's Still Expensive Walmart to Sell Cheaper Insulin; Advocates Say It's Still Expensive
ReliOn Novolog will cost less than brand-name versions, but some diabetes advocates say $73 a vial is still too much.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Walmart to Sell Cheaper Insulin; Still Expensive
Walmart to Sell Cheaper Insulin; Advocates Say It's Still Expensive (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 30, 2021 Category: General Medicine Source Type: news

Walmart to Offer Low-Priced Insulin
Title: Walmart to Offer Low-Priced InsulinCategory: Health NewsCreated: 6/29/2021 12:00:00 AMLast Editorial Review: 6/30/2021 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 30, 2021 Category: Endocrinology Source Type: news

Walmart to Offer Low-Priced Insulin
TUESDAY, June 29, 2021 -- Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products. Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2021 Category: Pharmaceuticals Source Type: news

Walmart to Offer Low-Priced Insulin
TUESDAY, June 29, 2021 -- Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products. Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2021 Category: General Medicine Source Type: news

Walmart Announces Its Own Brand of Low-Cost Analog Insulin
Walmart Inc. will offer its own brand of analog insulin for people with diabetes, an effort to boost its pharmacy business and counter Amazon.com Inc.’s recent push to sell more medications. The world’s largest retailer will begin selling ReliOn NovoLog this week in its U.S. pharmacies with a prescription, Walmart said in a statement Tuesday. The medicine will cost between 58% and 75% less than the current cash price of branded insulin products for uninsured patients, Walmart said. More than 3 million Walmart customers are diabetic, and the retailer already offers human insulin to them for about $25. But that t...
Source: TIME: Health - June 29, 2021 Category: Consumer Health News Authors: Matthew Boyle and Angelica LaVito / Bloomberg Tags: Uncategorized Companies wire Source Type: news

Walmart says it will offer less expensive version of insulin at $73 per via
Walmart's new insulin brand - in stores this week - costs $73 per vial or $86 for a pack of prefilled pens. That means savings up to $101 per vial or $251 per pack of pens. (Source: the Mail online | Health)
Source: the Mail online | Health - June 29, 2021 Category: Consumer Health News Source Type: news

Omnipod 5'Artificial Pancreas' Shows Benefit in Type 1 Diabetes Omnipod 5'Artificial Pancreas' Shows Benefit in Type 1 Diabetes
If approved by the FDA, it would be the third commercially available semiautomated insulin delivery system in the US and the first without tubing. Data suggest it works in children as young as 2 years old.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 27, 2021 Category: Drugs & Pharmacology Tags: Pediatrics News Source Type: news

Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation
In the adult liver, a population of facultative progenitor cells called biliary epithelial cells (BECs) proliferate and differentiate into cholangiocytes and hepatocytes after injury, thereby restoring liver function. In mammalian models of chronic liver injury, Notch signaling is essential for bile duct formation from these cells. However, the continual proliferation of BECs and differentiation of hepatocytes in these models have limited their use for determining whether Notch signaling is required for BECs to replenish hepatocytes after injury in the mammalian liver. Here, we used a temporally restricted model of hepatic...
Source: Signal Transduction Knowledge Environment - June 22, 2021 Category: Science Authors: Minnis-Lyons, S. E., Ferreira-Gonzalez, S., Aleksieva, N., Man, T. Y., Gadd, V. L., Williams, M. J., Guest, R. V., Lu, W.-Y., Dwyer, B. J., Jamieson, T., Nixon, C., Van Hul, N., Lemaigre, F. P., McCafferty, J., Leclercq, I. A., Sansom, O. J., Boulter, L., Tags: STKE Research Articles Source Type: news

Diabetes type 2: Best diet to help lower blood sugars – what to include?
DIABETES type 2 is a condition in which the body does not produce enough insulin to help regulate blood sugar levels. Diet and food choices is key when it comes to managing this condition. What is the best diet to help lower blood sugars? (Source: Daily Express - Health)
Source: Daily Express - Health - June 20, 2021 Category: Consumer Health News Source Type: news

How to get rid of visceral fat: Four of the worst foods to eliminate to burn belly fat
HOW TO get rid of visceral fat can become a rather scientific matter mainly due to the effect certain food groups have on the body which includes thyroid function, inflammation and insulin resistance. All of this can have a negative effect on the body making belly fat loss far more difficult. According to experts, what are the four worst food groups which should be eliminated from the diet to help burn belly fat? (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2021 Category: Consumer Health News Source Type: news

Diabetes type 2: A popular drink which reduces post-meal blood glucose and insulin levels
DIABETES type 2 symptoms could include nausea, vomiting, shortness of breath, or vision problems. As blood sugar levels rise, these symptoms could become dangerous. Drinking this popular health drink has been shown to lower a person's blood glucose levels after a meal and could help lower your blood sugar. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2021 Category: Consumer Health News Source Type: news

Adiposity Factors and Insulin Resistance in Obese Children Adiposity Factors and Insulin Resistance in Obese Children
How might different adiposity factors contribute to the development of insulin resistance in children and adolescents?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 18, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

AmalgamRx's insulin titration algorithm has green light in EU
The company also announced a commercialization deal with Novo Nordisk.   (Source: mobihealthnews)
Source: mobihealthnews - June 18, 2021 Category: Information Technology Source Type: news

NHS to give artificial pancreas to 1,000 diabetics to test if it prevents life-threatening attacks
Patients with type 1 diabetes will be able to use the devices, which continuously measure a person's glucose levels and deliver insulin directly to the bloodstream, Sir Simon Stevens said. (Source: the Mail online | Health)
Source: the Mail online | Health - June 16, 2021 Category: Consumer Health News Source Type: news

Patients with type 1 diabetes to get artificial pancreas
An ‘artificial pancreas’ designed to revolutionise the lives of people with Type 1 diabetes will be provided by the NHS, 100 years after the discovery of insulin, health service chief executive Sir Simon Stevens has announced. (Source: NHS Networks)
Source: NHS Networks - June 16, 2021 Category: UK Health Source Type: news

Eat Two Fruits a Day, Ward Off Diabetes? Eat Two Fruits a Day, Ward Off Diabetes?
Results from an observational Australian study'support encouragement of the consumption of whole fruits, but not fruit juice, to preserve insulin sensitivity and mitigate type 2 diabetes risk. 'Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - June 10, 2021 Category: Respiratory Medicine Tags: Cardiology News Source Type: news

To Fix America ’s Broken Health Care System, We Must Rethink Who Counts as an Expert
Americans are emerging from the COVID-19 pandemic like survivors of a wildfire surveying an unfamiliar landscape. As we take stock of what’s left, we are forced to rebuild, but we need not simply restore what was taken in a hollow echo of what we knew before. We can make health care and the infrastructure that supports it better, stronger, more resilient. To do that, as we learned at great cost over the past 15 months, we must value all the stakeholders in the system: not just insurance executives and hospital CEOs, but patients, disabled people, older adults, low-income people, people of color who have faced histori...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: s.e. smith Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans. Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body's response to insulin. (Source: World Pharma News)
Source: World Pharma News - June 10, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

' Remarkable' Response to Diabetes Drug for Bipolar Depression'Remarkable' Response to Diabetes Drug for Bipolar Depression
Patients with treatment-resistant bipolar depression with insulin resistance showed marked improvement in depressive symptoms after their insulin-resistance was mitigated by treatment with metformin.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 7, 2021 Category: Internal Medicine Tags: Psychiatry News Source Type: news

Research advances one step closer to stem cell therapy for type 1 diabetes
(Salk Institute) Scientists at the Salk Institute are developing a promising approach for treating type 1 diabetes by using stem cells to create insulin-producing cells (called beta cells) that could replace nonfunctional pancreatic cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

Chip mimicking bovine endometrium used in study of factors that can jeopardize pregnancy
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) The device was used for the first time to culture two maternal endometrial cell types, revealing the effects of alterations in glucose and insulin levels in the uterine environment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

Diabetes type 2 symptoms: Look inside of your mouth to spot signs of high blood sugar
DIABETES arises when the hormone insulin - a regulator for blood sugar - becomes less effective. People with high blood sugar levels are three times more likely to encounter dental issues than those who don't have the condition. What should you look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - June 6, 2021 Category: Consumer Health News Source Type: news

How to lose visceral fat: The drink proven to get rid of harmful belly fat
VISCERAL fat is a health hazard; carrying too much of the harmful belly fat can lead to insulin resistance, diabetes, and cardiovascular disease. How can you get rid of it? (Source: Daily Express - Health)
Source: Daily Express - Health - June 5, 2021 Category: Consumer Health News Source Type: news

Diabetes type 2 symptoms: Two indications on your face that are a sign of high blood sugar
DIABETES equates to poor blood sugar control, as the hormone insulin either becomes ineffective or not enough is being created. This autonomic process is not something you can control, but it is something you can influence. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2021 Category: Consumer Health News Source Type: news

CGM Tied to Better Glycemic Control in Insulin-Treated Diabetes
THURSDAY, June 3, 2021 -- For insulin-treated patients with diabetes, real-time continuous glucose monitoring (CGM) is associated with improvements in hemoglobin A1c (HbA1c) and reductions in emergency department visits and hospitalizations for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 3, 2021 Category: Pharmaceuticals Source Type: news

Continuous glucose monitors help diabetes patients control blood suger, reduce ER visits
Continuous glucose monitors can improve blood sugar control and reduce visits to the emergency room for hypoglycemia in patients with insulin-treated Type 2 diabetes, according to a study published Wednesday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 2, 2021 Category: Consumer Health News Source Type: news

Real-time continuous glucose monitoring, blood sugar control
(JAMA Network) What The Study Did: Researchers investigated the effect of real-time continuous glucose monitoring on glycemic control among patients with insulin-treated diabetes. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 2, 2021 Category: International Medicine & Public Health Source Type: news